Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB :: NOTCH1 fusions with unfavorable outcome

Blood (2024) 144 (13): 1412–1417.

https://doi.org/10.1182/blood.2024025307

Published: 2024

Includes: Supplemental data

Journal Articles

Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial

Heiner Zimmermann, Christian Koenecke, Martin H. Dreyling, Christiane Pott, Ulrich Dührsen, Dennis Hahn, Norbert Meidenbauer, Ingeborg A Hauser, Mathias J. Rummel, Dominik Wolf, Michael Heuser, Christian Schmidt, Peter Schlattmann, Matthias Ritgen, Reiner Siebert, Ilske Oschlies, Ioannis Anagnostopoulos, Ralf Ulrich Trappe

Blood (2021) 138 (Supplement 1): 3555.

https://doi.org/10.1182/blood-2021-146823

Published: 2021

Journal Articles

Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance

Blood (2021) 137 (17): 2347–2359.

https://doi.org/10.1182/blood.2020005381

Published: 2021

Includes: Supplemental data

Journal Articles

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

Wilhelm Woessmann, Martin Zimmermann, Andrea Meinhardt, Stephanie Müller, Holger Hauch, Fabian Knörr, Ilske Oschlies, Wolfram Klapper, Felix Niggli, Edita Kabickova, Andishe Attarbaschi, Alfred Reiter, Birgit Burkhardt

Blood (2020) 135 (14): 1124–1132.

https://doi.org/10.1182/blood.2019003591

Published: 2020

Includes: Supplemental data

Journal Articles

IG- MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

Blood (2018) 132 (21): 2280–2285.

https://doi.org/10.1182/blood-2018-03-842088

Published: 2018

Includes: Supplemental data

Journal Articles

Prognostic Impact of Immunohistochemistry and MRD Results in Bone Marrow after Frontline Chemoimmunotherapy of Chronic Lymphocytic Leukemia (CLL): Results of Central Laboratory Analyses of the CLL10 Trial of the German CLL Study Group (GCLLSG)

Blood (2017) 130 (Supplement 1): 3021.

https://doi.org/10.1182/blood.V130.Suppl_1.3021.3021

Published: 2017

Journal Articles

New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

Marius Rohde, Martin Zimmermann, Bettina R. Bonn, Monika Szczepanowski, Ilske Oschlies, Wolfram Klapper, MD, Anja Möricke, Martin Schrappe, Inga Nagel, Reiner Siebert, Alfred Reiter, MD, Birgit Burkhardt

Blood (2014) 124 (21): 2980.

https://doi.org/10.1182/blood.V124.21.2980.2980

Published: 2014

Journal Articles

Relapsed or Refractory Burkitt Lymphoma in Children and Adolescents after BFM-Type First-Line Therapy - a BFM Group Report

Wilhelm Woessmann, MD, Martin Zimmermann, Birgit Burkhardt, Andrea Meinhardt, MD, Christine Rosenbusch, MD, Vera Vaillant, MD, Ilske Oschlies, Wolfram Klapper, MD, Felix Niggli, MD, Andishe Attarbaschi, MD, Georg Mann, MD, Martin Schrappe, MD, Alfred Reiter, MD

Blood (2014) 124 (21): 1738.

https://doi.org/10.1182/blood.V124.21.1738.1738

Published: 2014

Journal Articles

Proposal of a Genetic Classifier for Risk Group Stratification in Pediatric T-Cell Lymphoblastic Lymphoma Reveals Significant Differences to T-Cell Lymphoblastic Leukemia

Bettina R. Bonn, Martin Zimmermann, PhD, Sebastian Balbach, Marius Rohde, Ilske Oschlies, Wolfram Klapper, MD, Olga Makarova, Claudia Rossig, MD, Birgit Burkhardt

Blood (2014) 124 (21): 2398.

https://doi.org/10.1182/blood.V124.21.2398.2398

Published: 2014

Journal Articles

A recurrent 11q aberration pattern characterizes a subset of MYC -negative high-grade B-cell lymphomas resembling Burkitt lymphoma

Blood (2014) 123 (8): 1187–1198.

https://doi.org/10.1182/blood-2013-06-507996

Published: 2014

Includes: Supplemental data

Journal Articles

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK –positive anaplastic large-cell lymphoma

Christine Damm-Welk, Lara Mussolin, Martin Zimmermann, Marta Pillon, Wolfram Klapper, Ilske Oschlies, Emanuele S. G. d’Amore, Alfred Reiter, Wilhelm Woessmann, Angelo Rosolen

Blood (2014) 123 (3): 334–337.

https://doi.org/10.1182/blood-2013-09-526202

Published: 2014

Includes: Supplemental data

Journal Articles

Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence

Bettina R. Bonn, Marius Rohde, Martin Zimmermann, David Krieger, Ilske Oschlies, Felix Niggli, Grazyna Wrobel, Andishe Attarbaschi, Gabriele Escherich, Wolfram Klapper, Alfred Reiter, Birgit Burkhardt

Blood (2013) 121 (16): 3153–3160.

https://doi.org/10.1182/blood-2012-12-474148

Published: 2013

Includes: Supplemental data

Journal Articles

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

Blood (2011) 118 (1): 139–147.

https://doi.org/10.1182/blood-2011-01-330795

Published: 2011

Includes: Supplemental data

Journal Articles

Non-Hodgkin Lymphoma in Adolescents: Experiences in 378 Adolescent NHL Patients Treated According to Pediatric NHL-BFM Protocols.

Birgit Burkhardt, MD, PhD, Ilske Oschlies, MD, Wolfram Klapper, MD, PhD, Martin Zimmermann, PhD, Andrea Meinhardt, MD, Eva Landmann, MD, Wilhelm Woessmann, MD, PhD, Georg Mann, MD, Felix Niggli, MD, Martin Schrappe, MD, PhD, Alfred Reiter, MD, PhD

Blood (2009) 114 (22): 102.

https://doi.org/10.1182/blood.V114.22.102.102

Published: 2009

Journal Articles

Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study

Marie-Cécile Le Deley, Alfred Reiter, Denise Williams, Georges Delsol, Ilske Oschlies, Keith McCarthy, Martin Zimmermann, Laurence Brugières

Blood (2008) 111 (3): 1560–1566.

https://doi.org/10.1182/blood-2007-07-100958

Published: 2008

Includes: Supplemental data

Journal Articles

Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK –positive anaplastic large-cell lymphoma

Christine Damm-Welk, Kerstin Busch, Birgit Burkhardt, Jutta Schieferstein, Susanne Viehmann, Ilske Oschlies, Wolfram Klapper, Martin Zimmermann, Jochen Harbott, Alfred Reiter, Willi Woessmann

Blood (2007) 110 (2): 670–677.

https://doi.org/10.1182/blood-2007-02-066852

Published: 2007

Includes: Supplemental data

Journal Articles

Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Münster) Multicenter Trial

Ilske Oschlies, Wolfram Klapper, Martin Zimmermann, Matthias Krams, Hans-Heinrich Wacker, Birgit Burkhardt, Lana Harder, Reiner Siebert, Alfred Reiter, Reza Parwaresch

Blood (2006) 107 (10): 4047–4052.

https://doi.org/10.1182/blood-2005-10-4213

Published: 2006

Journal Articles

The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95

Wilhelm Woessmann, Kathrin Seidemann, Georg Mann, Martin Zimmermann, Birgit Burkhardt, Ilske Oschlies, Wolf-Dieter Ludwig, Thomas Klingebiel, Norbert Graf, Bernd Gruhn, Heribert Juergens, Felix Niggli, Reza Parwaresch, Helmut Gadner, Hansjoerg Riehm, Martin Schrappe, Alfred Reiter, for the BFM Group

Blood (2005) 105 (3): 948–958.

https://doi.org/10.1182/blood-2004-03-0973

Published: 2005

Journal Articles

Epstein-Barr virus infection in Western European pediatric non-Hodgkin lymphomas

Matthias A. Karajannis, Michael Hummel, Ilske Oschlies, Ioannis Anagnostopoulos, Martin Zimmermann, Harald Stein, Reza Parwaresch, Alfred Reiter

Blood (2003) 102 (12): 4244.

https://doi.org/10.1182/blood-2003-08-2986

Published: 2003

NARROW

Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB :: NOTCH1 fusions with unfavorable outcome

Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial

Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

IG- MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

Prognostic Impact of Immunohistochemistry and MRD Results in Bone Marrow after Frontline Chemoimmunotherapy of Chronic Lymphocytic Leukemia (CLL): Results of Central Laboratory Analyses of the CLL10 Trial of the German CLL Study Group (GCLLSG)

New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

Relapsed or Refractory Burkitt Lymphoma in Children and Adolescents after BFM-Type First-Line Therapy - a BFM Group Report

Proposal of a Genetic Classifier for Risk Group Stratification in Pediatric T-Cell Lymphoblastic Lymphoma Reveals Significant Differences to T-Cell Lymphoblastic Leukemia

A recurrent 11q aberration pattern characterizes a subset of MYC -negative high-grade B-cell lymphomas resembling Burkitt lymphoma

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK –positive anaplastic large-cell lymphoma

Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

Non-Hodgkin Lymphoma in Adolescents: Experiences in 378 Adolescent NHL Patients Treated According to Pediatric NHL-BFM Protocols.

Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study

Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK –positive anaplastic large-cell lymphoma

Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Münster) Multicenter Trial

The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95

Epstein-Barr virus infection in Western European pediatric non-Hodgkin lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only